Connect with us

Media & Technology

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) Gaining as Phase III trial of DCVax®-L. Top Line Data Looms

Published

on

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is once again in full beast mode skyrocketing up the charts on a massive surge of volume as investors eagerly await top line data from the Phase III trial of DCVax®-L. Speculation is high that NWBO is on the verge of success where all others have failed. Including some very big names very recently; NWBO has an effective treatment/cure for the deadliest, most treatment resistant cancers.

Northwest recently reported Data Lock for the Phase III trial of DCVax®-L for Gliobastoma. This comes after a long 13 – year wait for investors. Expectations are sky high as we wait for top line data from the Phase III trial of DCVax®-L. Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer and represents a potential market expected to reach $1.4 billion by 2025 expanding at a CAGR of 12.6% during the forecast period, driven by rising geriatric population, growing incidence cases and rich clinical pipeline of new products. DCVax®-L has been featured by main stream press numerous times as many recovered patients have come forward crediting DCVax®-L for saving their lives.

Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NW Bio’s proprietary manufacturing technology enables the Company to produce its personalized vaccine in an efficient, cost-effective manner. The Company has a broad platform technology for DCVax dendritic cell-based vaccines. NWBO owns a valuable patent portfolio of 199 issued patents and 65 pending patent applications worldwide, grouped into 11 patent families.

Very recently NWBO made a big step forward in its path to drug approval was the “unblinding” of its 15-year trial for DCVAX-L. On Oct. 5, the company issued a press release detailing many steps that would ensue, including the unblinding of the company’s management of the results of the statistical analysis of the data. According to the pr from NWBO: With the database now locked, the independent service firms managing the Clinical Trial are arranging for the independent statisticians to have access to the unblinded raw data from the Trial. Neither the Company nor any party other than the independent statisticians will have access to any unblinded data at this stage.

Earlier this year NWBO acquired Flaskworks, a company that has developed a breakthrough system to close and automate the manufacturing of cell therapy products such as DCVax®.  Flaskworks was previously owned by its technical founders and Corning Incorporated.  The technical team from Flaskworks has joined NW Bio as part of the acquisition. It is anticipated that the Flaskworks system will enable substantial scale-up of production volumes of DCVax products and substantial reduction of production costs.

To Find out the inside Scoop on NWBO Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

NWBO

To date, the manufacture of immune cell therapies (including T cell therapies and others) has involved two major challenges.  First, the manufacturing processes involve “open” steps in which the product is open to the air in the manufacturing suite.  This necessitates extremely expensive “clean room” facilities with specialized infrastructure and specialized operating systems for sterile air and water, and personnel working in sterile lab suits (“space suits”).  Second, the manufacturing processes are mostly manual processes – in essence, hand crafted artisan processes by highly skilled technicians working under sterile conditions.

The Flaskworks system is also expected to significantly reduce production costs: turning “open” steps in the manufacturing process into “closed” steps, in which the product is not open to the air in the manufacturing suite, removing the need to build and operate the extremely costly clean room suites for those processes, and removing the need for personnel to work in sterile lab suits.  This will greatly reduce the DCVax-L production costs.  The buildout of the Sawston, UK facility has purposely been designed to proceed in phases, as modules, both for efficiency in the timing of capital costs and to allow flexibility in operations and usage.  Implementation of the Flaskworks system will enable certain phases of the buildout to be simplified and streamlined.

https://twitter.com/UnderShort/status/1343051923356864512

For More on NWBO Subscribe Right Now!

NWBO is once again in full beast mode skyrocketing up the charts on a massive surge of volume as investors eagerly await top line data from the Phase III trial of DCVax®-L. Speculation is high that NWBO is on the verge of success where all others have failed. Including some very big names very recently; NWBO has an effective treatment/cure for the deadliest, most treatment resistant cancers. Northwest recently reported Data Lock for the Phase III trial of DCVax®-L for Gliobastoma. This comes after a long 13 – year wait for investors. Expectations are sky high as we wait for top line data from the Phase III trial of DCVax®-L. Glioblastoma multiforme (GBM) is the most aggressive form of brain cancer and represents a potential market expected to reach $1.4 billion by 2025 expanding at a CAGR of 12.6% during the forecast period, driven by rising geriatric population, growing incidence cases and rich clinical pipeline of new products. DCVax®-L has been featured by main stream press numerous times as many recovered patients have come forward crediting DCVax®-L for saving their lives. positive results should provide Linda Powers and her board ample bargaining power to sell NWBO’s proprietary vaccine to the highest bidder, which would readily be in the $10 to $20 billion market cap range. Microcapdaily first reported on NWBO in 2018 and alerted investors on September 4, 2020 just as NWBO was taking off northbound. We will be updating on NWBO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NWBO.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in NWBO either long or short and we have not been compensated for this article.

Featured

VCI Global (NASDAQ: VCIG) Joins Forces with Microsoft Azure OpenAI: A Tech Revolution Unleashed

Published

on

VCI Global (NASDAQ: VCIG) is back on the radar with another significant gain of 84%. We wrote about this company just recently in June, where it popped 156% on the announcement of their “Socializer Messenger”. The company is now teaming up with Microsoft Azure OpenAI through its subsidiary, V Galactech Sdn Bhd. This partnership brings together their AI know-how to reshape the world of business solutions, making waves in the tech scene by using Microsoft Azure OpenAI services.

This collaboration is all about meeting the growing demand for tech advancements that are fast, smooth, and globally connected, helping businesses connect better with their customers. It’s also a boost to VCI Global’s AI consulting skills.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

By tapping into what Microsoft Azure OpenAI offers, VCI Global is jumping into the tech world’s fast lane. They plan to come up with some cool innovations, like Generative Pre-trained Transformer 4 (GPT-4) and Microsoft’s new AI-powered chat tool, Bing Chat Enterprise. Plus, they’ll use Microsoft Azure OpenAI’s cutting-edge AI for their projects, including the super-smart AI-assisted sales platform, robosale software.

https://twitter.com/ShortDaPos/status/1694403174566858783?s=20

Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global, is very excited about this partnership. He mentions, “We’re thrilled to dive deep into AI innovations, especially with Microsoft Azure OpenAI. We can’t wait to see how this partnership transforms how businesses connect with customers in the ever-changing tech world. The sky’s the limit, and we’re ready to help our clients ride this AI wave.”

About VCI Global Limited:

VCI Global is a versatile consulting group that’s all about helping businesses with their tech and strategy. They give advice on business strategies, help with investor relations, and provide tech know-how. They mainly work in Malaysia, but they also serve clients in Malaysia, China, Singapore, and the United States, covering a bunch of different industries.

If you want to know more about them, just head to https://v-capital.co/.

About Microsoft Azure Open AI:

Microsoft Azure OpenAI is like a treasure chest of artificial intelligence tools and solutions made to help businesses. They offer everything from AI Services to Machine Learning and AI infrastructure, all aimed at helping businesses make the most of AI for their growth and innovation.

We will update you on VCIG when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by Mohamed_hassan from Pixabay

Continue Reading

Featured

Mobilicom (NASDAQ: MOB) Secures Landmark Deal with Top Global Manufacturer

Published

on

Mobilicom (NASDAQ: MOB), a company providing cybersecurity and reliable solutions for drones and robotics secures its largest order to date from Teledyne Technologies Incorporated (NYSE: TDY) – shares rocket 123%. $TDY is one of the world’s largest manufacturers of small-sized drones and robotics.

Overview:
This $19B Tier-1 customer has now incorporated Mobilicom’s SkyHopper PRO into its latest small-sized drone platform. This is yet another testament to Mobilicom’s systems as they have already successfully integrated into 44 design wins by various drone and UAV manufacturers.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

More importantly, Teledyne has made significant progress in transitioning from the design phase to production and commercial sales with the U.S. Department of Defense. The company’s latest purchase order appears to reflect only the beginning of potentially multiple recurring orders as they prepare for their first-ever production order for the U.S. DOD.

“As Teledyne-FLIR continues to win additional orders for its small-sized drone platforms with end users such as the U.S. DOD, other federal agencies, and commercial customers, Mobilicom is well positioned for more sales of its Skyhopper Pro,” stated Mobilicom CEO Oren Elkayam. “We see the sales of these systems to the U.S. DOD, one of the largest and most selective procurers of technology, as a strong testament to the excellence of Mobilicom’s market-leading end-to-end solutions.”

 

About SkyHopper PRO:
The SkyHopper PRO is a communication system for drones that ensures secure data transfer. It offers a number of advantages and customization compared to competitors, here’s a quick overview:

Cybersecurity: Prioritizes cybersecurity, ensuring the secure transfer of data between the drone and the ground control station. This feature helps protect sensitive information and prevents unauthorized access or interference.

Reliability: The system is designed to provide robust and reliable communication even in challenging environments. It supports long-range and non-line-of-sight communication, enabling seamless connectivity between the drone and the ground station, even when obstacles are present.

Versatility: Supports multiple transmission modes, including point-to-point and point-to-multipoint communication. This versatility enables various communication setups, such as multi-drone operations and communication to multiple receivers, enhancing flexibility in drone missions.

Industry Integration: Systems have been integrated into numerous design wins by drone and UAV manufacturers indicating their compatibility and suitability for a wide range of platforms. The proven track record of integration demonstrates the system’s adaptability and reliability.

End-to-End Solution: End-to-end solutions for cybersecurity and robust communication. This comprehensive approach ensures seamless integration, streamlined operations, and enhanced overall performance for drone missions.

About Mobilicom:
Mobilicom is a leading provider of end-to-end cybersecurity and robust solutions for drones and robotics. They focus on serving global manufacturers in these industries, offering patented Mobile Mesh networking technology and a proven portfolio of commercialized products. With a growing high-profile global customer base, including corporations, governments, and the military, Mobilicom stands out for its outstanding security capabilities and performance in harsh environments. They derive revenue from hardware and software sales, licensing fees, and professional support services.

About Teledyne Technologies (NYSE: TDY):
Teledyne Technologies is a global leader known for its innovative solutions in aerospace and defense, environmental sensing, and digital imaging. The company’s success stems from a strong emphasis on research and development, enabling them to introduce cutting-edge technologies and meet customer needs effectively. With a focus on quality and customer satisfaction, Teledyne Technologies has earned a solid reputation in the industry. Strategic acquisitions have further strengthened their capabilities, expanding their product offerings and market reach. Through adaptability and a commitment to delivering value, Teledyne Technologies has established itself as a prominent player in various verticals in multiple industries, ultimately paving the way for the company’s current $19B stature in the market.

We will update you on MOB when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by Pexels from Pixabay

 

Continue Reading

Featured

Pagaya Technologies (NASDAQ: PGY) Experiences Astonishing Stock Surge: From Struggling to Thriving

Published

on

Shares of Pagaya Technologies (NASDAQ: PGY) have surged by nearly 70% since early Monday morning. This remarkable increase comes after a period when the global fintech company, known for its expertise in AI-driven financial infrastructure, was struggling to meet NASDAQ’s compliance standards and was trading below one dollar. However, the company’s latest news release has brought about a significant transformation, as Pagaya now appears to be trading strongly above the $1.00 mark.

The cause for these gains appear to be related to their latest announcement of successfully concluding its latest asset-backed securitization (ABS) transaction called PAID 2023-4. The transaction raised a total of $541 million, marking the 39th ABS transaction for Pagaya since 2018 and the seventh in 2023. Pagaya follows a unique funding model where capital is raised in advance before loan origination takes place, positioning them as the top issuer of personal loan ABS transactions in the United States.

Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Qualified institutional buyers acquired $541 million in asset-backed notes from this securitization, which primarily consisted of unsecured consumer loan assets. Over the years, Pagaya has conducted ABS transactions totalling more than $16 billion since 2018, providing funding for over $16 billion in new loan originations by US consumer lenders, all facilitated by the power of Pagaya’s AI technology.

Gal Krubiner, the Co-Founder and CEO of Pagaya, expressed confidence in their funding model, AI capabilities, and research and analytics teams, emphasizing the scalable opportunities and solutions they offer to partners and investors. He noted that this latest securitization exemplifies the ongoing strength and demand within Pagaya’s network, which consistently delivers value in the current economic climate.

Pagaya’s technology and network continue to prove their effectiveness. The recent securitization exemplifies how Pagaya’s AI network is uniquely positioned to source high-quality assets from various partners and connect them with top institutional investors, creating a mutually beneficial scenario for all parties involved.

We have come across an informative article that provides insights into the Fintech industry as a whole. The article discusses its notable growth in 2021 and explores the potential of the industry moving forward. You can access the article through the following link:https://ffnews.com/thought-leader/the-rise-and-fall-of-fintech-funding-an-outlook-on-the-fintech-ecosystem-in-2023-and-beyond/

Retail Investors:
Amidst these notable gains, retail investors are actively monitoring various algorithms and chart trends to identify potential entry points. We have compiled a few screenshots featuring ideas from other investors. Notably, one user named “Eliant Capital #4” has achieved significant gains and suggests the possibility of further movement. However it is important to do your own research and come up with your own conclusions, it can be quite risky utilizing the day trading mentality if you’re not experienced.

 

https://twitter.com/spacanpanman/status/1673369017946390528?s=20

Additionally, another user named “Dayna Louca” has shared a research update on the company. According to her analysis, $PGY is in the final stages of regulatory approval for their Mid West Clean Energy Project and has initiated a formal Expression of Interest (EOI) process to attract strategic or financial partners. For a comprehensive understanding and careful consideration before making any investment decisions, it would be beneficial to explore the details further. You can find more information and due diligence by referring to the following Tweet:

 

About Pagaya:
Pagaya Technologies (NASDAQ: PGY) is dedicated to democratizing access to life-changing financial products and services by leveraging machine learning, vast data networks, and sophisticated AI-driven approaches. Through its comprehensive consumer credit and residential real estate solutions, Pagaya serves partners, their customers, and investors. By integrating proprietary APIs and capital solutions, Pagaya ensures seamless user experiences and enhanced access to the mainstream economy.

We will update you on PGY when more details emerge, subscribe to Microcapdaily to follow along!

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.

Picture by Goumbik from Pixabay

 

 

 

Continue Reading

Trending

© All rights reserved.

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.